Taro Pharmaceuticals Pays $67.6M To Settle Generic Drug Pricing Class

Mealey's (November 16, 2021, 8:22 AM EST) -- HAIFA BAY, Israel — Generic drug maker Taro Pharmaceutical Industries Ltd. on Nov. 4 announced that subsidiary Taro Pharmaceuticals U.S.A. Inc. has agreed to pay $67,643,000 to settle direct purchaser class...
To view the full article, register now.